AOD-9604 Protocol Guide: The Complete Physician-Supervised Approach to Fat Loss & Body Composition
AOD-9604 (Advanced Obesity Drug) is a modified fragment of human growth hormone (amino acids 176-191) that stimulates fat breakdown without the side effects associated with full growth hormone therapy. This guide covers evidence-based dosing, timelines, and how Hatter Labs physicians optimize your fat loss protocol.
Protocol Quick Reference
Who Is This Protocol For?
AOD-9604 is designed for individuals who want to reduce body fat, particularly stubborn adipose tissue that resists diet and exercise, without the risks of full growth hormone therapy. Common candidates include:
- Adults with stubborn body fat who maintain a healthy diet and exercise routine but struggle with localized fat deposits (abdomen, love handles, thighs)
- Individuals who want fat loss without GH side effects such as insulin resistance, water retention, joint pain, or carpal tunnel syndrome
- Those in body recomposition phases aiming to reduce fat while preserving or building lean mass
- Post-menopausal women or andropause-age men experiencing hormonal shifts that drive visceral fat accumulation
- Anyone seeking a non-stimulant fat loss approach that works through natural lipolytic pathways
AOD-9604 is not recommended for individuals with active cancer, pregnant or breastfeeding women, or those expecting dramatic weight loss without lifestyle support. It is a body composition optimization tool, not a magic bullet. Your Hatter Labs physician will assess candidacy based on labs and body composition analysis.
How AOD-9604 Works: Mechanism of Action
AOD-9604 is a synthetic peptide corresponding to the fat-burning region of human growth hormone. Critically, it retains the lipolytic (fat-burning) activity of GH while lacking the growth-promoting and diabetogenic effects that make long-term GH use problematic.
Primary Mechanisms
- Lipolysis stimulation: AOD-9604 activates beta-3 adrenergic receptors on adipocytes, triggering the breakdown of stored triglycerides into free fatty acids and glycerol. This mimics the fat-burning action of GH without stimulating IGF-1 production.
- Lipogenesis inhibition: Beyond breaking down existing fat, AOD-9604 inhibits the formation of new fat by blocking lipogenic enzymes. This dual action — burning existing fat while preventing new fat storage — makes it particularly effective.
- No impact on blood sugar: Unlike full-length GH, AOD-9604 does not affect insulin sensitivity or blood glucose levels. Multiple clinical studies have confirmed no changes in glucose tolerance, IGF-1, or insulin levels.
- Cartilage regeneration: Interestingly, AOD-9604 has shown cartilage repair properties in preclinical studies. It stimulates proteoglycan and collagen production in chondrocytes, leading to its investigation as an osteoarthritis treatment in Australia.
- Selective fat targeting: AOD-9604 preferentially targets visceral and subcutaneous fat stores rather than lean tissue, preserving muscle mass during fat loss protocols.
Clinical Note: AOD-9604 has been through human clinical trials (Phase 2b), demonstrating statistically significant fat loss versus placebo in obese individuals. The Australian Therapeutic Goods Administration has granted it GRAS (Generally Recognized As Safe) status. It remains one of the best-studied peptides for fat loss with a clean safety profile.
Detailed Protocol
AOD-9604 is administered daily on an empty stomach to maximize absorption and fat-burning effect. Your Hatter Labs physician will calibrate dosing based on body composition analysis and metabolic labs.
| Parameter | Standard Protocol | Intensive Protocol |
|---|---|---|
| Daily Dosage | 250 mcg/day | 500 mcg/day |
| Frequency | Once daily | Once daily (or 250 mcg 2x daily) |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Injection Site | Abdominal fat pad (near target fat) | Abdominal fat pad or stubborn fat area |
| Duration | 8-10 weeks | 10-12 weeks |
| Time of Day | Morning, fasted (30 min before food) | Morning fasted + pre-bed (if split) |
| Cycling | 8 weeks on, 4 weeks off | 12 weeks on, 4-6 weeks off |
Personalization Note: Hatter Labs uses DEXA scans or bioimpedance analysis at baseline and follow-up to track body composition changes objectively. Your physician evaluates metabolic panels, thyroid function, and hormone levels to ensure fat loss is supported by your overall metabolic health.
What to Expect: Results Timeline
Week 1-2: Metabolic Priming Phase
- - Subtle increase in warmth and metabolic activity, especially during exercise
- - Slight reduction in appetite for some individuals
- - No significant visible changes yet — lipolytic pathways are being activated
- - Mild injection site reactions may occur (normal and temporary)
Week 3-6: Active Fat Loss Phase
- - Noticeable reduction in abdominal fat and waist measurements
- - Clothes fitting differently, particularly around the midsection
- - Improved body composition ratios on measurements
- - Enhanced exercise-induced fat burning (pair with cardio for best results)
- - No muscle loss — lean mass maintained or improved with resistance training
Week 7-12: Consolidation Phase
- - Significant body composition improvement measurable on DEXA scan
- - Stubborn fat deposits visibly reduced
- - Improved lipid panel results (cholesterol, triglycerides)
- - Many patients report 2-5% body fat reduction when combined with exercise
- - Your physician evaluates results and plans next steps (continue, cycle off, maintain)
AOD-9604 results are significantly enhanced by consistent exercise (both resistance and cardiovascular training) and a caloric deficit or maintenance-level diet. It is not a substitute for healthy habits — it amplifies them.
Potential Side Effects
AOD-9604 has a GRAS (Generally Recognized As Safe) designation from Australian regulators. Clinical trials showed a side effect profile comparable to placebo. However, as with any injectable therapy:
Common (mild, usually transient)
- Injection site redness, minor swelling, or itching
- Mild headache during the first few days of use
- Slight euphoria or energy increase (not unpleasant)
- Temporary flu-like symptoms as fat metabolism increases
Uncommon (report to your physician)
- Persistent headaches or dizziness
- Chest tightness or unusual cardiovascular symptoms
- Significant mood changes
- Allergic reaction (rash, swelling, difficulty breathing) — seek immediate medical attention
Safety Note: AOD-9604 does not affect IGF-1 levels, blood sugar, or growth hormone signaling. It is one of the safest peptides available for fat loss. However, individuals with cardiovascular disease should be monitored, as rapid changes in lipid metabolism can affect cardiovascular markers. Your Hatter Labs physician checks lipid panels throughout treatment.
Stacking Options
AOD-9604 combines naturally with other metabolic and body composition peptides for synergistic fat loss and recomposition results.
AOD-9604 + MOTS-c
A dual-mechanism fat loss stack. AOD-9604 directly stimulates lipolysis in fat cells while MOTS-c activates AMPK for enhanced fat oxidation and metabolic rate. The combination attacks fat from two independent pathways for superior results.
AOD-9604 + CJC-1295/Ipamorelin
Combines targeted fat loss with growth hormone optimization. CJC-1295/Ipamorelin stimulates natural GH pulsatile release for lean mass support, sleep improvement, and recovery, while AOD-9604 handles fat reduction without the insulin sensitivity concerns of exogenous GH.
AOD-9604 + MOTS-c + Ipamorelin (Recomposition Stack)
The comprehensive body recomposition protocol. Fat burning from two mechanisms (AOD-9604 + MOTS-c) combined with GH-mediated lean mass support (Ipamorelin). This stack is ideal for those wanting significant body composition changes while maintaining or building muscle.
Why Run Your AOD-9604 Protocol with Hatter Labs
AOD-9604 works best when dosing is calibrated to your body composition, metabolic profile, and activity level. Hatter Labs provides the data-driven physician oversight that turns a good peptide into an optimized protocol.
Physician-Supervised Protocols
Licensed physicians design and monitor your protocol from start to finish
Personalized Dosing Based on Labs
DEXA scans, metabolic panels, and lipid profiles guide your exact dosing
Direct Doctor Chat & Remote Consultations
Message your physician anytime with questions or concerns, schedule video calls
Before & After Lab Testing
Track body composition, lipid panels, and metabolic markers objectively
Pharmaceutical-Grade Compounds
Premium peptides sourced from licensed US compounding pharmacies with full purity testing
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. AOD-9604 is a research peptide that requires a physician prescription. Individual results vary. Always consult with a qualified healthcare provider before starting any peptide therapy protocol. Hatter Labs protocols are supervised by licensed physicians who evaluate your health history, contraindications, and treatment goals before prescribing.